DATASHEET
Host:
Mouse
Target Protein:
IKB alpha
Immunogen Range:
1-77/314
Clonality:
Monoclonal
Isotype:
IgG
Entrez Gene:
P25963
Swiss Prot:
4792
Source:
Recombinant human IKB alpha Protein
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles.
Background:
Three major forms of IKB like molecules have been identified and each is characterised by multiple copies of ankyrin repeats. IKB alpha and IKB beta appear to be the major regulatory forms of IKB in most cells. These proteins interact with p65 or cRel containing forms of NFkB and block nuclear import by masking the nuclear localisation sequences of NFkB. The activation of NFkB involves the inducible phosphorylation and subsequent degradation of IKB. Immunoblotting easily detects the hyperphosphorylated forms of IKB alpha, but not phosphorylated IKB beta. Interestingly, IKB alpha and IKB beta mediate different NFkB responses. IkB alpha appears to control more transient activation of NFkB in response to an inducer, while IKB beta controls a persistent response. Bcl3 interacts with p50 and p52 containing forms of NFkB, but rather than being an inhibitor it appears to function to stimulate transcription. The degradation of IKB is confirmed by immunoblotting.
PRODUCT SPECIFIC PUBLICATIONS
- Mingdong Si. et al. <em>Gentianella acuta</em> mitigates cardiovascular damage and inflammation in diet?induced hypercholesterolaemic rats. Exp Ther Med. 2021 Nov;22(5):1-1Read more>>
- Gan Rao. et al. Arsenic and polystyrene-nano plastics co-exposure induced testicular toxicity: Triggers oxidative stress and promotes apoptosis and inflammation in mice. ENVIRON TOXICOL. 2023 SepRead more>>
VALIDATION IMAGES
Lane 1: Jurkat cell lysates probed with IKB alpha Monoclonal Antibody, Unconjugated (bsm-33441M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Human 293T cell lysates probed with IKB alpha Monoclonal Antibody, Unconjugated (bs-33441M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Human HepG2 cell lysates; Lane 2: Human Hela cell lysates; Lane 3: Human Siha cell lysates probed with IKB alpha Monoclonal Antibody, Unconjugated (bsm-33441M) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.